News | CT Angiography (CTA) | August 21, 2015

Loyola University Medical Center First in Illinois to Implement FFR-CT

CT scans can determine blood flow through diseased coronary arteries to determine if a stent is needed

FFR-CT

An example of a FFR-CT study showing a 3-D reconstruction of the coronary tree and a color overlay of virtual FFR readings, including a severe blockage in need of revascularization in the left anterior decending artery.

August 21, 2015 — Loyola University Medical Center is the first and only hospital in Illinois to offer a new, noninvasive technology to test for coronary artery disease.

The technology employs noninvasive CT scans to calculate how much blood is flowing through diseased coronary arteries that have narrowed due to a buildup of plaque. The patient does not need to undergo an invasive angiogram that involves threading a catheter to the heart.

The test, developed by HeartFlow Inc., has been approved by the U.S. Food and Drug Administration. It’s called fractional flow reserve-computed tomography (FFR-CT).

“FFR-CT provides superior patient care and helps guide treatment strategies with a single, non-invasive study that is low risk and provides accurate information,” said cardiologist Mark Rabbat, M.D., FSCCT, an assistant professor in the departments of Medicine and Radiology of Loyola University Chicago Stritch School of Medicine.

Rabbat said FFR-CT can answer important clinical questions such as whether a patient has coronary artery disease. It can determine whether plaque in a coronary artery is restricting blood flow, thereby helping determine whether a patient would benefit from stents or bypass surgery.

More than 16 million adults in the United States have coronary artery disease. The condition occurs when a buildup of plaque narrows arteries that supply oxygen-rich blood to heart muscle. Reduced blood flow to heart muscles can cause angina (chest pain) and shortness of breath. If an artery becomes completely blocked, a patient can suffer a heart attack.

Blockages that reduce blood flow by a small amount can be treated with medical therapy such as cholesterol-lowering drugs or aspirin. But if there is a major reduction in blood flow, the patient may require a stent or bypass surgery.

Until now, the standard test for measuring FFR involved an invasive angiogram and use of an FFR catheter. 

If blood flow is reduced, the blood pressure downstream from the blockage also will be reduced. If this blood pressure is less than 80 percent of the blood pressure in the aorta, a cardiologist may recommend a stent or bypass surgery.

The new FFR-CT technique is noninvasive. CT scans create a digital 3-D model of the arteries leading to the heart. Powerful computer models then simulate the blood flow within those arteries to assess whether blood flow has been restricted by any narrowings. A color-coded map helps physicians determine, vessel by vessel, if sufficient blood is flowing to the heart.

“FFR-CT is a game changer,” Rabbat said. “For the first time, we have a single comprehensive, non-invasive diagnostic test that offers both an anatomic assessment and the functional significance of coronary artery disease. We’re proud to be the first hospital in Illinois to offer this revolutionary technology to our patients.”

For more information: www.loyolamedicine.org

Related Content

SIIM Announces Keynote Speakers for Conference on Machine Intelligence in Medical Imaging
News | Artificial Intelligence | September 21, 2017
The Society for Imaging Informatics in Medicine (SIIM) recently announced several corporate and government experts as...
News | Imaging | September 18, 2017
Mary Washington Hospital and Union Health-Union Hospital will both receive Safety FiRsT grants to implement safety...
Understanding True Patient-centered Care in Radiology
Sponsored Content | Whitepapers | Imaging | September 18, 2017
What is the true meaning of “patient-centered care”?
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT) | September 15, 2017
September 15, 2017 — Hitachi Healthcare Americas Inc. announced it has attained U.S.
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
ASRT Donating $10,000 in Support of Hurricane Irma Relief Efforts
News | Business | September 12, 2017
September 12, 2017 — The American Society of Radiologic Technologists (ASRT) announced it will donate $10,000 to the
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT) | September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
News | Imaging | September 11, 2017
September 11, 2017 — Innovatus Imaging Corp., a newly created holding company formed by private equity firm Resilienc
Overlay Init